ENVIVO PHARMACEUTICALS

EnVivo Pharmaceuticals, a privately-held biotech company

#SimilarOrganizations #People #More

ENVIVO PHARMACEUTICALS

Industry:
Biotechnology Health Care

Status:
Active


Similar Organizations

bgm-pharmaceuticals-logo

Bgm Pharmaceuticals

Bgm Pharmaceuticals is a privately owned Biotechnology company

misfolding-diagnostics-logo

Misfolding Diagnostics

Misfolding Diagnostics is a privately held biotech company.

tagworks-pharmaceuticals-logo

Tagworks Pharmaceuticals

Tagworks Pharmaceuticals is a privately held biotech company

Current Employees Featured

deborah-dunsire_image

Deborah Dunsire
Deborah Dunsire President and Chief Executive Officer @ EnVivo Pharmaceuticals
President and Chief Executive Officer
2013-01-01

More informations about "EnVivo Pharmaceuticals"

EnVivo Pharmaceuticals, Inc. Becomes FORUM ... - Fierce Biotech

WATERTOWN, Mass. โ€“ April 2, 2014 โ€“ EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. The new name better โ€ฆSee details»

EnVivo Pharmaceuticals, Inc. Becomes FORUM Pharmaceuticals

Apr 2, 2014 WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. โ€ฆSee details»

FORUM Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

FORUM Pharmaceuticals, formerly known as EnVivo Pharmaceuticals, is a biopharmaceutical company dedicated to discovering and developing therapeutics for disorders of the central โ€ฆSee details»

EnVivo Pharmaceuticals - Crunchbase Company Profile & Funding

EnVivo Pharmaceuticals, a privately-held biotech company. New. Resources. Advanced Search. Start Free Trial . Talk With Sales ... Experience the new Crunchbase, powered by AI . โ€ฆSee details»

Watertown biotech EnVivo changes name to Forum โ€ฆ

The new name for the biotech formerly known as EnVivo Pharmaceuticals, and headed by former Millennium CEO Deborah Dunsire, is meant to reflect "the company's strong position as a late โ€ฆSee details»

EnVivo Pharmaceuticals - Drug pipelines, Patents, Clinical trials

Explore EnVivo Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 3 news, and 3 literature, Disease Domain:Nervous System Diseases, Technology โ€ฆSee details»

Deborah Dunsire - President and Chief Executive โ€ฆ

Jan 20, 2015 Primary Organization . EnVivo Pharmaceuticals . Gender Female; ... Dr. Dunsire has served as President and Chief Executive Officer of EnVivo Pharmaceuticals since July 2013. Before joining EnVivo, she served as โ€ฆSee details»

โ˜‘๏ธFORUM Pharmaceuticals (Formerly EnVivo Pharmaceuticals, โ€ฆ

FORUM Pharmaceuticals (Formerly EnVivo Pharmaceuticals, Inc.) โ€” Consulting Organization from USA, it`s involved in Health sectorSee details»

EnVivo Pharmaceuticals, Inc - VentureRadar

Clora has revolutionized how the fastest growing biotechs access the right talent at the right time, foregoing traditional hiring and outsourcing models, to strengthen their competitive โ€ฆSee details»

EnVivo Pharmaceuticals, Inc. Becomes FORUM ... - Business Wire

Apr 2, 2014 EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. ... purpose-built organization that is focused on โ€ฆSee details»

EnVivo Pharmaceuticals - Contacts, Employees, Board Members, โ€ฆ

Organization. EnVivo Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 6. ... EnVivo โ€ฆSee details»

FRM 0334 - AdisInsight - Springer

Feb 22, 2018 FORUM Pharmaceuticals (formerly EnVivo Pharmaceuticals) was developing FRM 0334 (formerly EVP 0334) for the treatment of neurodegenerative disorders, including ... If โ€ฆSee details»

Fidelity invests $65 in EnVivo Pharma, takes over

Oct 31, 2008 Neurological-drug developer EnVivo Pharmaceuticals received $65 million in a series D round closed in April, bringing EnVivo's total venture financing to nearly $125 million. The big spender isSee details»

Ex-Millennium: The Takeda Oncology Company CEO to Head โ€ฆ

Jul 11, 2013 EnVivo Pharmaceuticals, Inc., based in Watertown, Mass., is a privately held company working to convert its broad pipeline into a range of CNS therapies that leverage โ€ฆSee details»

Watertown biotech EnVivo changes name to Forum โ€ฆ

The new name for the biotech formerly known as EnVivo Pharmaceuticals, and headed by former Millennium CEO Deborah Dunsire, is meant to reflect โ€œthe companyโ€™s strong position as a late โ€ฆSee details»

EnVivo Pharmaceuticals - Overview, News & Similar companies

EnVivo Pharmaceuticals, Inc. and its subsidiaries ("EnVivo Pharmaceuticals" or "EnVivo") are dedicated to discovering and developing small molecule therapeutics for disorders of the โ€ฆSee details»

| CenterWatch

Jul 12, 2013 EnVivo Pharmaceuticals, developing a range of novel therapies for central nervous system (CNS) diseases, has named Deborah Dunsire, M.D., president and chief executive โ€ฆSee details»

EnVivo Enters Phase 2b Trials for Its EVP-6124 Compound in the ...

Jan 5, 2010 EnVivo Pharmaceuticals, located in Watertown, Mass., is a biopharmaceutical company dedicated to discovering and developing small molecule therapeutics for disorders of the central nervous system ...See details»

Ex-Millennium: The Takeda Oncology Company CEO to Head โ€ฆ

Jul 12, 2013 EnVivo Pharmaceuticals Announces Appointment of Deborah Dunsire, M.D., as President and Chief Executive Officer WATERTOWN, Mass.--(BUSINESS WIRE)-- EnVivo โ€ฆSee details»

EnVivo Pharmaceuticals Locations - Contract Research Map

Watertown, MA, USA EnVivo Pharmaceuticals provides drug discovery and development for nervous system disorders. More. ... Information about my organization is incorrect, how do I fix โ€ฆSee details»

linkstock.net © 2022. All rights reserved